Domain names: No roving on Jaguar��s cyber land

Posted on 13 January 2017

Famous worldwide as a manufacturer of premium vehicles, Jaguar Land Rover Limited (the complainant) owns numerous trade marks, including Australian national trade marks, for JAGUAR, LAND ROVER and RANGE ROVER.

Jennifer Heath

Senior Associate, Trade Mark Attorney

News

Hanns-Juergen Grosse joins our Munich team

Posted on 06 January 2017

Hanns-Juergen Grosse joins D Young & Co LLP’s patent electronics, engineering & IT practice.

Newsletter

Trade Mark Newsletter No.90

Posted on 01 January 2017

IP Cases & Articles

Patentability of products of biological processes

Posted on 23 December 2016

In our December patent newsletter [see note 1 below] we reported the publication of a notice from the European Commission on its interpretation of certain aspects of the so-called 'Biotech Directive' (Directive 98/44/EC). A conclusion of the notice was inter alia that under Article 4 of the Biotech Directive, there…

IP Cases & Articles

Raytheon: On-demand instantiation in a computing system

Posted on 16 December 2016

On the 22 June 2016 the Technical Board of Appeal issued its decision (T 1742/12) regarding an appeal concerning the selection of closest prior art when it is ambiguous as to which document is closest to the claimed arrangement.

Ryan Lacey

Senior Associate, Patent Attorney

IP Cases & Articles

Patent litigation: expedited cases and numerical limits

Posted on 16 December 2016

In our October 2016 newsletter we commented on patent litigation in the UK in the light of Brexit. As we noted there, UK patent litigation proceedings have a strong reputation for quality, which will endure, and real efforts are being made to improve costs and efficiency.

IP Cases & Articles

Undisclosed disclaimers - Enlarged Board of Appeal

Posted on 16 December 2016

New questions have been referred to the EPO Enlarged Board of Appeal regarding the allowability of disclaimers.

Catherine Keetch

Partner, Patent Attorney

IP Cases & Articles

Hospira v Genentech - Herceptin formulation obvious

Posted on 16 December 2016

In July this year, the Court of Appeal handed down a decision in Hospira v Genentech [2016] EWCA Civ 780 which upheld the decision by Birss J in November 2014 to revoke the two Herceptin formulation patents for obviousness and added matter.

Rachel Bateman

Partner, Patent Attorney

IP Cases & Articles

Warner Lambert v Actavis: Swiss form claims��

Posted on 16 December 2016

The Court of Appeal has decided the latest instalment of the pregabalin second medical use litigation between Warner-Lambert (part of Pfizer) and Actavis (and other generics manufacturers) in the UK.

IP Cases & Articles